Pengaruh Pemilihan Anti-Psikotik Pada Pasien Depresi Tanpa dan Dengan Gejala Psikotik Terhadap Lama Hari Rawat Inap
Abstract
Antipsychotic therapy is given frequently to the patient with depressive symptoms. Antipsychotics are used to enhance the effects of antidepressants in the depressive patients. The aim of this study was to evaluate the length of stay of antipsychotic therapy selection in the depressive patient without/with psychosis symptoms. This study was conducted by quantitative method, multicenter, non-experimental approach, and cohort design study. Data were collected from medical records of 187 patients diagnosed with depression without/with psychosis symptoms from the various mental-illness hospital in Central Java Province. There was a significant difference (p <0.05) in the length of stay with the selection of antidepressants in depressive patients without psychotic symptoms, and there was no significant difference (p> 0.05) in the length of stay with the selection of antipsychotic agents in depressive patients without/with psychotic symptoms.
Keywords— Length of stay, depression, without/with psychosis symptoms, antipsychotic
Full Text:
References
V.A SBJ dan S. Depression and Bipolar Disorder. In: A
Grebb Jack, editor. Kaplan & Sadock’s Synopsis of
Psychiatry: Behavioral Sciences/Clinical Psychiatry.
th Edition, Lippincott Williams & Wilkins; 2007, p.
–1.
American Psychiatric Association. Mood Disorder.
Diagnostic and Statistical Manual of Mental Disorder.
th edition, Washington DC: Text Revision; 2000.
Barbosa L, Berk M, Vorster M. A double-blind,
randomized, placebo-controlled trial of augmentation
with lamotrigine or placebo in patients concomitantly
treated with fluoxetine for resistant major depressive
episodes. The Journal of Clinical Psychiatry
;64:403–7.
Kennedy SH, Lam RW. Enhancing outcomes in the
management of treatment-resistant depression: a focus
on atypical antipsychotics. Bipolar Disorders 2003;5:36–
doi:10.1111/j.1399-2406.2003.00058.x.
Keck PE. Bipolar depression: a new role for atypical
antipsychotics? Bipolar Disorders 2005;7:34–40.
doi:10.1111/j.1399-5618.2005.00213.x.
McIntyre RS, Filteau M-J, Martin L, Patry S, Carvalho
A, Cha DS, et al. Treatment-resistant depression:
Definitions, review of the evidence, and algorithmic
approach. Journal of Affective Disorders 2014;156:1–7.
doi:10.1016/J.JAD.2013.10.043.
Keck, P. E., Jr., Strakowski, S. M., & McElroy SL. The
efficacy of atypical antipsychotics in the treatment of
depressive symptoms, hostility, and suicidality in
patients with schizophrenia. The Journal of Clinical
Psychiatry 2000;61:4–9.
Tohen M, Zhang F, Taylor CC, Burns P, Zarate C,
Sanger T, et al. A meta-analysis of the use of typical
antipsychotic agents in bipolar disorder. Journal of
Affective Disorders 2001;65:85–93. doi:10.1016/S0165-
(00)00162-2.
Rothschild AJM, Williamson DJMb, Tohen MFM,
Schatzberg A, Anderson S, Van Campen LE, et al. A
Double-Blind, Randomized Study of Olanzapine and
Olanzapine... : Journal of Clinical Psychopharmacology.
Journal of Clinical Psychopharmacology 2004;Volume
:365–73.
Ussher JM. Are We Medicalizing Women’s Misery? A
Critical Review of Women’s Higher Rates of Reported
Depression. Feminism & Psychology 2010;20:9–35.
doi:10.1177/0959353509350213.
Bangasser DA, Curtis A, Reyes BAS, Bethea TT,
Parastatidis I, Ischiropoulos H, et al. Sex differences in
corticotropin-releasing factor receptor signaling and
trafficking: potential role in female vulnerability to
stress-related psychopathology. Molecular Psychiatry
;15:896–904. doi:10.1038/mp.2010.66.
Douma SL, Husband C, O’Donnell ME, Barwin BN,
Woodend AK. Estrogen-related mood disorders:
reproductive life cycle factors. ANS Advances in
Nursing Science 2005;28:364–75.
Kessler RC. Epidemiology of women and depression.
Journal of Affective Disorders 2003;74:5–13.
doi:10.1016/S0165-0327(02)00426-3.
Bennett HA, Einarson A, Taddio A, Koren G, Einarson
TR. Prevalence of Depression During Pregnancy:
Systematic Review. Obstetrics & Gynecology
;103:698–709.
doi:10.1097/01.AOG.0000116689.75396.5f.
Bogner HR, Gallo JJ. Are higher rates of depression in
women accounted for by differential symptom reporting?
Social Psychiatry and Psychiatric Epidemiology
;39:126–32. doi:10.1007/s00127-004-0714-z.
Ismail SK. Gangguan Depresi. Buku Ajar Psikiatri,
Jakarta: Fakultas Kedokteran Universitas Indonesia;
Buysse DJ, Angst J, Gamma A, Ajdacic V, Eich D,
Rössler W. Prevalence, Course, and Comorbidity of
Insomnia and Depression in Young Adults. Sleep
;31:473–80. doi:10.1093/sleep/31.4.473.
Stahl SM. Mechanism of action of serotonin selective
reuptake inhibitors. Serotonin receptors and pathways
mediate therapeutic effects and side effects. Journal of
Affective Disorders 1998;51:215–35.
Hirschfeld RMA. Efficacy of SSRIs and newer
antidepressants in severe depression: comparison with
TCAs Authors’ objectives Methods of synthesis How
were the studies combined? Journal of Clinical
Psychiatry 1999. doi:DOI:10.4088/JCP.v60n0511.
Vasant S. A prospective comparative study on
tolerability and safety of amitryptiline and fluoxetine in
patients with depression. World Journal of
Pharmaceutical Research 2016;5:934–42.
Nierenberg AA. The treatment of severe depression: Is
there an efficacy gap between SSRI and TCA
antidepressant generations? The Journal of Clinical
Psychiatry 1994;55:55–9.
Anton RF Jr BEJ. Amoxapine versus amitriptyline
combined with perphenazine in the treatment of
psychotic depression. American Journal of Psychiatry
;147:1203–8. doi:10.1176/ajp.147.9.1203.
Bondolfi G, Eap C, Bertschy G, Zullino D, Vermeulen
A, Baumann P. The Effect of Fluoxetine on the
Pharmacokinetics and Safety of Risperidone in Psychotic
Patients. Pharmacopsychiatry 2002;35:50–6.
doi:10.1055/s-2002-25026.
Hillert A, Maier W, Wetzel H, Benkert O. Risperidone
in the Treatment of Disorders with a combined Psychotic
and Depressive Syndrome - A Functional Approach.
Pharmacopsychiatry 1992;25:213–7. doi:10.1055/s-
-1014408.
Wu C-S, Hsieh MH, Tang C-H, Chang C-J. Comparative
effectiveness of long-acting injectable risperidone vs.
long-acting injectable first-generation antipsychotics in
bipolar disorder. Journal of Affective Disorders
;197:189–95. doi:10.1016/J.JAD.2016.03.043.
DOI: https://doi.org/10.30591/pjif.v8i2.1469
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Â
===============================================================
Parapemikir : Jurnal Ilmiah Farmasi
Program Studi D-3 Farmasi
Politeknik Harapan Bersama Tegal
Jl. Mataram No.09 Pesurungan Lor Kota Tegal
Telp. +62283 - 352000
Email :[email protected]
Â
Copyright: Parapemikir : Jurnal Ilmiah Farmasi p-ISSN:2089-5313 e-ISSN:2549-5062
Â
===============================================================
Â
Parapemikir Indexed By :Â
 |  |  |  |
 |  |  |  Â |
Â
This work is licensed under a Creative Commons Attribution 4.0 International License.
